{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:47:43Z","timestamp":1772682463627,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002845","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T13:25:28Z","timestamp":1562160328000},"page":"e1002845","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-4366","authenticated-orcid":true,"given":"Yoon Hong","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-0097","authenticated-orcid":true,"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.vaccine.2012.04.093","article-title":"Pneumococcal vaccines WHO position paper\u2013 2012 \u2013Recommendations","volume":"30","author":"WHO Publication","year":"2012","journal-title":"Vaccine"},{"key":"ref2","unstructured":"World Health Organization; Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper\u2013February 2019. Accessed 12th March 2019"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"D Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-10-90","article-title":"Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease","volume":"10","author":"A Melegaro","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e26190","DOI":"10.1371\/journal.pone.0026190","article-title":"7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?","volume":"6","author":"YH Choi","year":"2011","journal-title":"PLoS ONE"},{"key":"ref6","first-page":"1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"3099","author":"E Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"D Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"S Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e39927","DOI":"10.1371\/journal.pone.0039927","article-title":"Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales","volume":"7","author":"YH Choi","year":"2012","journal-title":"PLoS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"PA Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1001839","DOI":"10.1371\/journal.pmed.1001839","article-title":"The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries","volume":"12","author":"S Flasche","year":"2015","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"SN Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S0950268805004012","article-title":"A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting","volume":"133","author":"M Hussain","year":"2005","journal-title":"Epidemiol Infect"},{"key":"ref14","unstructured":"Slack M, Hinds J, Gould K, Manglani S, Choi YH, Sheppard C, et al. The impact of multiple serotype carriage detection by microarray-based molecular serotyping in two UK nasopharyngeal carriage studies. Poster presentation at ISPPD-9 in Hyderabad, India, 2014."},{"key":"ref15","unstructured":"Office for National Statistics. Population estimates between 1956 and 2030 in England and Wales. [cited 2019 Mar 12]; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ons.gov.uk\/\" xlink:type=\"simple\">https:\/\/www.ons.gov.uk\/<\/ext-link>."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"JJ Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e76180","DOI":"10.1371\/journal.pone.0076180","article-title":"The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young","volume":"8","author":"AJ van Hoek","year":"2013","journal-title":"PLoS ONE"},{"key":"ref18","unstructured":"Public Health England. Vaccine uptake guidance and the latest coverage data. 2018. [cited 2019 Mar 12]; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.gov.uk\/government\/collections\/vaccine-uptake\" xlink:type=\"simple\">https:\/\/www.gov.uk\/government\/collections\/vaccine-uptake<\/ext-link>."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: A postlicensure indirect cohort study","volume":"14","author":"NJ Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/CVI.00117-10","article-title":"Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster","volume":"17","author":"FM Russell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref21","unstructured":"Lewnard JA, Givon_Lavi N, Dagan R. Dose-specific effectiveness of 7- and 13-valent pneumococcal conjugate vaccines against vaccineserotype Streptococcus pneumoniae colonization: a matched, case-control study. bioRxiv. 2019; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1101\/532085\" xlink:type=\"simple\">https:\/\/doi.org\/10.1101\/532085<\/ext-link>."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1164\/rccm.201510-2000OC","article-title":"The Effects of Live Attenuated Influenza Vaccine on Nasopharyngeal Bacteria in Healthy 2 to 4 Year Olds. A Randomized Controlled Trial","volume":"193","author":"V Thors","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0195799","DOI":"10.1371\/journal.pone.0195799","article-title":"Pneumococcal carriage in children and their household contacts six years after introduction of the 13- valent pneumococcal conjugate vaccine in England","volume":"13","author":"J Southern","year":"2018","journal-title":"PLoS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A Simplex Method for Function Minimization","volume":"7","author":"JA Nelder","year":"1965","journal-title":"Comput J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2334-6-14","article-title":"S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools","volume":"6","author":"S Cauchemez","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"C Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/thoraxjnl-2011-200671","article-title":"Community-acquired pneumonia in children","volume":"66","author":"A Thomson","year":"2011","journal-title":"Thorax"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-018-1004-z","article-title":"Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control","volume":"16","author":"D Thorrington","year":"2018","journal-title":"BMC Medicine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/cid\/cix310","article-title":"Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006\u20132014","volume":"65","author":"G Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjmed.2017.06.039","article-title":"Effect of Age on the Manifestations and Outcomes of Invasive Pneumococcal Disease in Adults","volume":"131","author":"TJ Marrie","year":"2018","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/cid\/cit791","article-title":"Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5\u201315 years in England and Wales","volume":"58","author":"SN Ladhani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2005.02.008","article-title":"The current burden of pneumococcal disease in England and Wales","volume":"52","author":"A Melegaro","year":"2006","journal-title":"J Infect"},{"key":"ref33","unstructured":"Daniel P, Bewick T, Welham S, Lim WS. Adult Community Acquired Pneumonia (CAP) Audit Report. British Thoracic Society. 2015. [cited 2019 Mar 12]; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.brit-thoracic.org.uk\/media\/70418\/adult-cap-audit-report-2014-15.pdf\" xlink:type=\"simple\">https:\/\/www.brit-thoracic.org.uk\/media\/70418\/adult-cap-audit-report-2014-15.pdf<\/ext-link>."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1513\/AnnalsATS.201512-848OC","article-title":"The impact of age and comorbidities on the mortality of patients of different age groups admitted with community-acquired pneumonia","volume":"13","author":"CM Luna","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"ref35","unstructured":"JCVI. Minute of the Joint Committee on Vaccination and Immunisation meeting on 04 October 2017. [cited 2019 Mar 12]; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/247634612957\" xlink:type=\"simple\">https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/247634612957<\/ext-link>."},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/aje\/kwy219","article-title":"Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children","volume":"188","author":"DM Weinberger","year":"2016","journal-title":"AJE"},{"issue":"Suppl 2","key":"ref37","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage","volume":"33","author":"KE Fleming-Dutra","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/INF.0000000000000717","article-title":"The efficacy and duration of protection of pneumococcal conjugate vaccines against nasopharyngeal carriage: A meta-regression model","volume":"34","author":"O Le Polain De Waroux","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1080\/21645515.2018.1467201","article-title":"Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam","volume":"14","author":"O Le Polain De Waroux","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.2009.975","article-title":"Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children","volume":"302","author":"EJM van Gils","year":"2009","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/infdis\/jiv761","article-title":"Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage","volume":"213","author":"JA Lewnard","year":"2016","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1371\/journal.pone.0028435","article-title":"Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales","volume":"5","author":"N Andrews","year":"2011","journal-title":"PLoS ONE"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"NJ Andrews","year":"2012","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S095026881800198X","article-title":"Dynamic transmission modelling to address infant pneumococcal conjugate vaccine schedule modifications in the UK","volume":"146","author":"M Wasserman","year":"2018","journal-title":"Epidemiol Infect"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/MD.0000000000000335","article-title":"A Cross-Sectional Observational Study of Pneumococcal Carriage in Children, Their Parents, and Older Adults Following the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine","volume":"94","author":"M Hamaluba","year":"2015","journal-title":"Med"},{"issue":"1771","key":"ref46","doi-asserted-by":"crossref","first-page":"20131939","DOI":"10.1098\/rspb.2013.1939","article-title":"The impact of specific and non-specific immunity on the ecology of <italic>Streptococcus pneumoniae<\/italic> and the implications for vaccination","volume":"280","author":"S Flasche","year":"2013","journal-title":"Proc Biol Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.1215947","article-title":"Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes","volume":"335","author":"S Cobey","year":"2012","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e56079","DOI":"10.1371\/journal.pone.0056079","article-title":"Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination","volume":"8","author":"M Nurhonen","year":"2013","journal-title":"PLoS ONE"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jinf.2013.02.007","article-title":"Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK","volume":"66","author":"EJ Nicoli","year":"2013","journal-title":"J Infect"},{"key":"ref50","unstructured":"Choi YH, Melegaro A, van Hoek AJ, Roca A, Mackenzie G, Gay N. Impact of thirteen-valent Pneumococcal Conjugate Vaccine on pneumococcal carriage in different countries\u2014Mathematical modelling study. Poster presentation at ISPPD-9 in Hyderabad, India, 2014."}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:30:45Z","timestamp":1588959045000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002845"}},"subtitle":[],"editor":[{"given":"Mirjam E. E.","family":"Kretzschmar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002845","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]}}}